Paparo Francesco, Panvini Nicola, Montale Amedeo, Pigati Maria, Marinaro Eugenio, Melani Enrico Francesco, Piccardo Arnoldo, Molini Lucio
Diagnostic Imaging Unit, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Gastroenterology Unit, E.O. Ospedali Galliera, Mura Delle Cappuccine 14, 16128, Genoa, Italy.
Abdom Radiol (NY). 2024 Jun;49(6):2083-2097. doi: 10.1007/s00261-024-04201-2. Epub 2024 Mar 5.
Patients with Crohn's disease (CD) are at increased risk of developing small bowel cancer, since chronic inflammation may trigger the histopathological sequence that begins from low-grade dysplasia of the intestinal epithelium and may eventually lead to malignant transformation. Owing to their location in a portion of the gastrointestinal tract which is not easily accessible to conventional endoscopic techniques, the detection of CD-related small bowel cancers is still a clinical challenge. The radiological features of CD-related small bowel adenocarcinoma (SBA) in patients with CD have been described in some previous studies, including its appearance in both CT and MRI examinations. Radiological signs of active or fibrostenotic CD may be intermixed with those suggesting the presence of CD-related SBA. In CT studies, the most relevant findings consistent with malignant transformation are the presence of a stricture with irregular asymmetric thickening of small bowel walls, loss of mural stratification, and moderate enhancement after intravenous administration of iodinated contrast media, in association with enlarged adjacent mesenteric lymph nodes. Many of the CD-related SBA features that can be observed on CT imaging are similar to those detectable by MRI. This latter modality provides the additional value of the functional characterization of small bowel strictures, thereby helping to distinguish between inflammatory, fibrotic, and malignant stenosis in the setting of active CD. Positron Emission Tomography (PET)/CT enables the metabolic assessment of enlarged mesenteric lymph nodes, and PET/MRI fusion imaging can incorporate morphological, functional and metabolic information into a single set of imaging data, thus overcoming the limitations of the separate assessment of each individual modality. Owing to the low incidence and prevalence of this long-term complication of CD, we believe that a detailed multimodality pictorial essay on this topic, also including the PET-CT and fusion imaging documentation of some cases, would be useful to the medical literature.
克罗恩病(CD)患者患小肠癌的风险增加,因为慢性炎症可能引发从肠上皮低度发育异常开始的组织病理学序列,并最终可能导致恶性转化。由于其位于胃肠道的一部分,传统内镜技术不易到达,检测与CD相关的小肠癌仍是一项临床挑战。先前的一些研究已经描述了CD患者中与CD相关的小肠腺癌(SBA)的放射学特征,包括其在CT和MRI检查中的表现。活动性或纤维狭窄性CD的放射学征象可能与提示存在与CD相关的SBA的征象相互混杂。在CT研究中,与恶性转化最相关的发现是小肠壁出现不规则不对称增厚的狭窄、壁分层消失,以及静脉注射碘化造影剂后中度强化,并伴有相邻肠系膜淋巴结肿大。许多在CT成像上可观察到的与CD相关的SBA特征与MRI可检测到的特征相似。后一种检查方式提供了小肠狭窄功能特征的额外价值,从而有助于在活动性CD的情况下区分炎症性、纤维化性和恶性狭窄。正电子发射断层扫描(PET)/CT能够对肿大的肠系膜淋巴结进行代谢评估,而PET/MRI融合成像可以将形态学、功能和代谢信息整合到一组成像数据中,从而克服了对每种单独检查方式进行单独评估的局限性。由于CD这种长期并发症的发病率和患病率较低,我们认为一篇关于该主题的详细多模态影像学论文,包括一些病例的PET-CT和融合成像记录,将对医学文献有所帮助。